Gene targeting experiments have revealed that transcription factors such as c-Myb and GATA-1 play crucial roles during hematopoietic dierentiation. c-Myb is necessary in the immature cells of almost every hematopoietic lineage and GATA-1 is essential for the development of the erythroid lineage. In addition, CREB-binding protein (CBP) acts as a transcriptional adapter for various transcription factors, including cMyb and GATA-1. In this paper, we show that the transcription factors c-Myb and GATA-1 each inhibit the transcriptional activity of the other and that any possible bipartite complexes c-Myb, GATA-1, and CBP could be formed, but the tripartite complex was hardly formed. The exclusive binding of GATA-1 and c-Myb to CBP is probably the molecular basis for the mutual inhibition of their transcriptional activity. Our data suggest that cross-talk between these three factors might be important for hematopoietic dierentiation and that CBP functions as a key molecule during the process.
Introduction
The c-myb proto-oncogene encodes a sequence-speci®c DNA binding protein containing three homeo domainrelated DNA binding repeats (repeats 1, 2 and 3) (Lipsick, 1996; Ness, 1996) . c-Myb is thought to regulate the growth and dierentiation of immature hematopoietic cells since adult-type hematopoiesis in homozygous c-myb mutant mice is greatly impaired (Mucenski et al., 1991) . Meanwhile only truncated versions of c-Myb eciently transform hematopoietic cells, and in vitro experiments have con®rmed that both termini of c-Myb contribute to its negative regulation (Ferrao et al., 1995; Gonda et al., 1989a,b; Grasser et al., 1991) .
Unlike the requirement for c-Myb by immature hematopoietic cells in almost every hematopoietic lineage, the zinc ®nger protein GATA-1 only functions in certain lineages. GATA-1 is abundantly expressed in erythroid and megakaryocytic cells, and its cognate DNA-binding motif is present in the cis-regulatory elements of virtually all characterized genes speci®cally expressed in these lineages (Orkin, 1992) . Gene inactivation experiments have demonstrated that GATA-1 is essential for terminal dierentiation of erythroid precursors (Fujiwara et al., 1996; Pevny et al., 1991; Simon et al., 1992; Takahashi et al., 1997; Weiss et al., 1994) and for the maturation of megakaryocytes (Shivdasani et al., 1997) .
CREB-binding protein (CBP) and its close homolog p300 have been described as co-activators (Lundblad et al., 1995) . CBP was originally reported as a coactivator of CREB (Chrivia et al., 1993; Kwok et al., 1994) , however it turned out to be a multifunctional co-activator of various transcription factors, including c-Myb and GATA-1 (Blobel et al., 1998; Dai et al., 1996; Mink et al., 1997; Oelgeschlager et al., 1996) . In this study, we reveal the inhibitory interaction of cMyb and GATA-1, which is probably mediated by CBP. Our data suggest the importance of the mutual inhibition of lineage and dierentiation stage speci®c transcription factors in regulating hematopoiesis.
Results

c-Myb and GATA-1 each inhibit the transcriptional activity of the other
First, we examined whether the transcriptional activities of c-Myb and GATA-1 interacted, by using a luciferase reporter gene (GATA-1/Luc) driven by the GATA-1 promoter. This promoter was positively regulated by GATA-1 itself but was activated only slightly by c-Myb alone (open squares in Figure 1a and open circles in Figure 1b) . The GATA-1-induced transactivation was modi®ed by the coexpression of c-Myb (Figure 1b) . Interestingly, the suppressive eect of c-Myb was not detectable with C-terminal truncated c-Myb (Dc-Myb) in which the C-terminal negative regulatory domain is deleted but the transcriptional activation domain is conserved ( Figure 1c) .
Next, we examined 6MBS/Luc reporter gene, in which activity is driven by six tandem repeats of the Myb binding site. This promoter was positively regulated by c-Myb, but was not aected by GATA-1 alone (open squares in Figure 1d and open circles in Figure 1e ). GATA-1 inhibited the transcriptional activity of c-Myb (Figure 1d ,e) but did not inhibit that of Dc-Myb (Figure 1f) . Namely, the eects of cMyb on the transcriptional activation of GATA-1/Luc and 6MBS/Luc were quite dierent from those of DcMyb. Authentic mouse myeloperoxidase (MPO) promoter and chicken mim-1 promoter, which contain Myb binding sites and are transactivated by c-Myb (Ness et al., 1989; Orita et al., 1997) , gave essentially same result (data not shown).
GATA-1 binds to c-Myb and CBP
The molecular mechanisms of the direct interaction between c-Myb and GATA-1 was examined. As shown in Figure 2a , c-Myb bound to GST-GATA-1 through repeats 2 and 3 of c-Myb which is thought to have important roles in hematopoietic cell dierentiation (Introna et al., 1990; Ogata et al., 1994) . Both c-Myb and Dc-Myb contain repeats 2 and 3, and were able to bind to GATA-1 (data not shown). As shown in Figure  2b , the GST-c-Myb fusion protein showed the direct binding of c-Myb with the N-terminal zinc ®nger domain of GATA-1. The binding capacity of these domains was also con®rmed in vivo as shown in Figure  2c . Thus, c-Myb and GATA-1 interact via their DNA binding domains. Both c-Myb and GATA-1 were recently reported to utilize the transcriptional coactivator CBP. It is reasonable to postulate that the competitive utilization of CBP by these two transcription factors accounts for their mutual transcriptional inhibition. Our data agree with a previous report (Blobel et al., 1998) , but we obtained some data that supplement the previous report. GATA-1 was reported S-labeled c-Myb and its truncated forms were incubated with puri®ed GST-GATA-1 (lanes 3, 4 and 8) or GST (lanes 5, 6 and 9) bound to Glutathione-Sepharose beads. (b) Structure of the GATA-1 proteins used for the binding assay (Top). WT, TA, N-f and C-f stand for wild-type, transcriptional activation domain, N-terminal zinc ®nger domain and C-terminal zinc ®nger domain, respectively. In vitro translated 35 S-labeled GATA-1 and its deletion mutants are shown in lanes 1, 4 ± 6. 10% of the 35 S-labeled proteins used for binding analyses was loaded in these lanes.
35 S-labeled GATA-1 truncated forms were incubated with puri®ed GST-c-Myb (lanes 2, 7 ± 9) or GST (3, 10 ± 12) bound to Glutathione-Sepharose beads. (c) In vivo two-hybrid interaction. 293T cells were cotransfected with the luciferase reporter plasmid containing three GAL4-binding sites (GBS) and the expression plasmid for the fusion protein of GAL4 DNA binding domain (GAL4 DBD) and GATA-1 Nterminal zinc ®nger domain (GATA-1 N-f). The control expression plasmid (Control, left bar) or the expression plasmid for the transactivation domain of VP16 only (VP16TA, middle bar) or that of the fusion protein of repeats 2 and 3 of c-Myb and VP16TA (Myb-VP16TA, right bar) was co-transfected. The Myb-VP16TA fusion protein stimulated the luciferase activity more than 20-fold, although VP16 alone had no eect. The result represents three independent experiments. Data are shown as mean+standard deviation
Interaction between Myb and GATA-1 T Takahashi et al to bind to the cysteine-histidine-rich region 3 of CBP (C/H3), but our in vitro binding assay showed that GATA-1 also bound to CBP via C/H1 (Figure 3 ) but did not bind to the KIX domain (data not shown). A mammalian two-hybrid analysis showed that while both C/H1 and C/H3 domains bound to GATA-1, the binding of C/H1 was a little stronger than that of C/ H3 (data not shown). Furthermore, transient expression of the C/H1 domain inhibited the GATA-1 induced transcriptional activation of GATA-1/Luc (Figure 3c ). These data strongly suggests that C/H1 binds to GATA-1 as well as C/H3.
In order to examine that the mutual inhibition of GATA-1 and c-Myb (Figure 1 ) was caused via competitive CBP utilization, it was examined whether over-expression of CBP or p300 could rescue the mutual inhibition. As shown in Figure 4 , both the transcriptional inhibition of GATA-1/Luc by c-Myb and that of 6MBS/Luc by GATA-1 were signi®cantly releaved by CBP or p300.
Tripartite complex of GATA-1, c-Myb and CBP is not produced
It is important to determine whether the tripartite complex consisting of c-Myb (or Dc-Myb), GATA-1 and CBP can form. Since the dierences between the binding characteristics of c-Myb and Dc-Myb would provide some clues to the dierences in their transcriptional interaction (Figure 1 ). Initially, the CBP domains required for binding to c-Myb and DcMyb were determined. c-Myb bound to both the KIX and the C/H1 domains as shown previously (Oelgeschlager et al., 1996) , however, Dc-Myb bound only to the KIX domain in vitro ( Figure 5a ). Next, an in vitro binding analysis by GST pull-down assay was used to determine whether GATA-1 bound to the complex of CBP and c-Myb (or Dc-Myb). The results show that GATA-1 bound to the KIX-Dc-Myb complex, while only a very small amount of GATA-1 bound to the S-labeled CBP and its truncated forms were incubated with puri®ed GST-GATA-1 (lanes 2, 7 ± 9, 14, and 17) or puri®ed GST (lanes 3, 10 ± 12, 15 and 18) bound to Glutathione-Sepharose beads. (c) CV-1 cells were transfected with GATA-1/Luc reporter plasmid, GATA-1 expressing plasmid (4 mg), and various amounts of C/H1 domain expressing plasmid Figure 4 Relief of the mutual inhibition of GATA-1 and c-Myb by CBP or p300. CV-1 cells were transfected with GATA-1/Luc or 6MBS/Luc reporter plasmids, with various combinations of expressing plasmids of GATA-1 (8 mg), c-Myb (8 mg), CBP (6 mg) and p300 (6 mg) in the case of GATA-1/Luc, GATA-1 (8 mg), cMyb (1 mg), CBP (6 mg) and p300 (6 mg) in the case of 6MBS/ Luc. Data are shown as mean+s.
d. of three samples
Interaction between Myb and GATA-1 T Takahashi et al KIX-c-Myb complex (Figure 5b) . In other words, the tripartite complex of CBP-Dc-Myb-GATA-1 formed readily, while that of CBP-c-Myb-GATA-1 rarely formed.
Further in vitro co-immunoprecipitation analysis of the tripartite complex formation strongly supported the notion that c-Myb and GATA-1 could not bind to CBP at the same time, but Dc-Myb and GATA-1 could ( Figure 6 ). In this experiment, CBP was ®rst incubated with a saturating dose of GATA-1, and then c-Myb was added to the mixture (Figure 6a , lane 5). The reverse experiment revealed that GATA-1 did not bind to the CBP-c-Myb complex and c-Myb did not bind to the CBP-GATA-1 complex (Figure 6a , lane 7). On the other hand, GATA-1 was coimmunoprecipitated with the CBP-Dc-Myb complex and Dc-Myb was co-immunoprecipitated with the CBP-GATA-1 complex (Figure 6b, lanes 5 and 7) . It is unlikely that direct binding between c-Myb and GATA-1 aected their DNA binding activity and subsequently caused the transcriptional inhibition. Since the addition of c-Myb did not aect the DNA binding activity of GATA-1 (Figure 7 ) and the addition of GATA-1 did not aect the DNA binding activity of c-Myb (data not shown). Taken together, it seems reasonable to postulate that failure of the formation of tripartite complex of c-Myb, GATA-1 and CBP brings about the mutual inhibition of transcriptional activity, while the complex of DcMyb, GATA-1 and CBP produces a synergistic eect.
Discussion
Mechanisms for the mutual repression of GATA-1 and c-Myb
The two transcription factors c-Myb and GATA-1 have pivotal roles in hematopoiesis and both utilize CBP as a transcriptional co-activator. c-Myb inhibited the GATA-1-induced transcriptional activation of GATA-1/Luc, while GATA-1 reduced the c-Mybinduced transcriptional activation of 6MBS/Luc. GATA-1 binds to c-Myb via their DNA binding domains. However, it is unlikely that the mutual repression of transcriptional activation was caused by interference with DNA binding of the activator proteins (Johnson, 1995) . Because mutual repression was not observed between GATA-1 and Dc-Myb, although GATA-1 bound to both Dc-Myb and cMyb via the DNA binding domain, R23. Instead, we propose that the exclusive binding characteristics of cMyb and GATA-1 to CBP account for the transcrip- Interaction between Myb and GATA-1 T Takahashi et al tional interference of these two transcription factors. The bipartite complex of any combinations of c-Myb, GATA-1, and CBP forms, but the tripartite complex of all three factors is rarely produced.
Dc-Myb enhanced the GATA-1-induced transactivation of GATA-1/Luc ten times more than activation by GATA-1 alone, which is strikingly dierent from the inhibitory activity of c-Myb (Figure 1b,c) . It is reasonable to consider that this synergistic activation might account for the oncogenic activity of avian vMyb since mouse Dc-Myb used in this study is structurally similar to avian v-Myb. We examined whether AMV type v-Myb (AMV-Myb) had the synergistic transactivation activity as well as Dc-Myb by co-transfection assay. Although slight enhancement was observed but the enhancement by AMV-Myb was signi®cantly less than that by Dc-Myb (data not shown). Dierence of the enhancement might be due to the species dierence between avian and murine Myb or to the point mutations in AMV-Myb.
There are two ways to explain the inhibitory interaction of two transcription factors via the competitive utilization of CBP. One example is seen in the inhibitory action of steroid hormone receptors on AP-1 activation (Chakravarti et al., 1996; Kamei et al., 1996) . AP-1 and a steroid hormone receptor bind to CBP at the same time and competitive utilization of the tripartite complex by the AP-1 binding site and steroid hormone responsive elements causes the inhibition. However, the mutual inhibition of c-Myb and GATA-1 must result from a dierent mechanism, because c-Myb and GATA-1 cannot bind to CBP at the same time, although they can bind to it separately. We assume that binding of either c-Myb or GATA-1 causes some conformational change in CBP and the inability to bind to the other transcription factor occurs.
GATA-1 and its transcriptional partners
The multiple ®nger protein FOG has been identi®ed as a candidate cofactor for GATA-1 (Tsang et al., 1997) . Both FOG and c-Myb bind to the N-zinc ®nger of GATA-1, but their functions are completely opposite. FOG enhances transactivation by GATA-1, while cMyb inhibits it. The shared binding domain of GATA-1 for FOG and c-Myb suggests that FOG and c-Myb interact with GATA-1 competitively. If c-Myb were expressed in the presence of FOG, c-Myb would function as a negative regulator of FOG. Conversely, if FOG were expressed in the presence of c-Myb, the inhibitory action of c-Myb on GATA-1 would be diminished. Thus, FOG would accelerate erythroid dierentiation by modifying the GATA-1 activity, while c-Myb would inhibit it. At the same time, cMyb also inhibits the transcriptional activation of GATA-1 by the competitive utilization of CBP described above. Taken together, c-Myb probably inhibits GATA-1 activity via the two transcriptional co-activators of GATA-1.
Potential roles of CBP in erythroid dierentiation
A switch in transcription state must occur during erythroid cell dierentiation, from the immature uncommitted state to a lineage-restricted state. We propose a model in which CBP functions as a molecular switch for this transition. There is abundant c-Myb in undierentiated hematopoietic progenitors, and the transcription of the presumptive c-Mybresponsive genes essential for the immature state is activated. Even if GATA-1 expression occurs during this stable state, the large amount of c-Myb suppresses GATA-1 activity by competitive binding to CBP. As in this paper, however, once the amount of c-Myb decreases in the presence of small amounts of GATA-1, the transcriptional activity of GATA-1 increases. At a subsequent point, positive autoregulatory circuits of GATA-1 expression are activated via the GATA-1 promoter, and FOG replaces the ubiquitous, multifunctional co-activator CBP and functions as a lineage-speci®c co-activator.
In this model, once the expression of GATA-1 exceeds a hypothetical threshold and the level of c-Myb simultaneously falls below another, then sequential dierentiation caused by the increased GATA-1 activity occurs autonomously by suppressing the effect of c-Myb. This`dierentiation' switch caused by thē uctuation of c-Myb and GATA-1 levels probably exists, because recent studies revealed that a small number of lineage-restricted genes are expressed randomly before dierentiation is initiated and their level of expression¯uctuates (Cross et al., 1997; Hu et al., 1997) . The onset of erythroid dierentiation and the suppression of c-Myb-responsive genes can be explained by the competitive binding of c-Myb and GATA-1 to CBP, at least in part. In this regard, CBP functions as a key molecule leading to erythroid commitment because of its limited amount in nuclei.
Materials and methods
Plasmids
pGATA-1/Luc was constructed by inserting GATA-1 promoter (bases 7798 to 7574) into the SmaI site of pRBGP3 (Igarashi et al., 1994) . The HincII/ HindIII fragment of pA10CAT6MBS-1 (Nakagoshi et al., 1990) were inserted into the SmaI/HindIII sites of pGL2-Basic vector (Promega, Madison, WI, USA) to generate p6MBS/Luc. Murine GATA-1 cDNA was inserted under the EF-1a promoter of pEF-BOS (Mizushima and Nagata, 1990) . The C/H1 domain expressing plasmid was produced by inserting murine CBP (amino acids 287 ± 447) into pCAGGS (Niwa et al., 1991) . The c-Myb and CBP expressing plasmids were described previously (Chrivia et al., 1993; Le et al., 1984; Sakura et al., 1989) . Dc-Myb spans from amino acids 1 ± 325 (Sakura et al., 1989) . The GAL4 fusion protein expression plasmid containing the DNA binding domain of GAL4 (amino acids 1 ± 147) fused to the N-terminal zinc ®nger domain of GATA-1 (amino acids 185 ± 257) was produced using a PCR-based method (Higuchi, 1990 ). This fusion protein was expressed by pcDNA3 (Invitrogen, San Diego, CA, USA). The Myb-VP16 and its reporter plasmid were described previously (Kanei Ishii et al., 1997) . pGST-CBP265 (KIX, amino acids 460 ± 683) and pGST-c-Myb CTL were used to express various forms of GST-CBP and GSTMyb fusion proteins in E. coli (Dai et al., 1996; Nomura et al., 1993) . pGST-C/H1 and pGST-GATA-1 were made by inserting the mouse CBP cDNA fragment (amino acids 287 ± 447) and the blunted NcoI fragment of GATA-1 cDNA into the SmaI site of the pGEX-2T (Pharmacia, Uppsala, Sweden) vector, respectively. pSPUTK (Stratagene, San Diego, CA, USA) was used to construct the plasmids for in vitro transcription/translation. The pSPUTK-c-Myb expression plasmid and its mutants were as reported (Kanei Ishii et al., 1997) . pSPUTK-C/H1 was made by inserting the PvuII fragment of C/H1 into pSPUTK after blunt ending its NcoI site. The DNA sequences corresponding to the indicated regions were ampli®ed by PCR and subcloned into pSPUTK to construct other expression plasmids for in vitro transcription/translation.
Reporter gene assay
The luciferase cotransfection assay was carried out as described (Nakagoshi et al., 1990) . Transfected cells were harvested 44 ± 48 h after transfection. The amount of lysate used for the luciferase assays was normalized with bgalactosidase activity expressed by the co-transfected plasmid pact-b-gal or pCMV-b-gal, or with luciferase activity expressed by pRLTK (Promega). All the luciferase cotransfection experiments were repeated at least three times and representative data from three independent experiments are shown.
Protein expression and in vitro-binding analysis with GST fusion proteins
Expression and preparation of GST-CBP, GST-GATA-1, GST-c-Myb fusion proteins, GST alone, full-length c-Myb, or Dc-Myb were carried out as described (Nomura et al., 1993; Yasukawa et al., 1995) . In vitro translation was carried out using the TNT reticulocyte lysate system (Promega).
Bacterial lysates containing GST or GST fusion proteins were rocked at 48C for 2 h with Glutathione-Sepharose beads (Pharmacia). The beads were washed ®ve times with cold PBS and once with binding buer (20 mM HEPES pH 7.8, 75 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 1% skim milk, 1 mM DTT, 0.05% NP-40).
35
S-labeled samples produced by in vitro translation were added to 500 mL of binding buer containing the preabsorbed beads and then the mixture was rocked at 48C for 2 h. The beads were washed ®ve times with cold PBS and mixed with SDS sample buer (Laemmli, 1970) . The bound proteins were released by boiling, and analysed by SDS ± PAGE and autoradiography.
The GST pull-down assay of the tripartite complex was carried out as following. Twenty mg of GST-KIX or GST were incubated with Glutathione-Sepharose beads in binding buer and washed three times with binding buer. The beads were resuspended in binding buer containing 200 mg of either c-Myb or Dc-Myb protein, which was bacterially expressed with thioredoxin, and rocked at 48C for 1 h. Then, in vitro translated [ 35 S]CH1 and GATA-1 were added to the mixture, rocked at 48C for 2 h and then washed four times with binding buer. The bound proteins analysed as described above.
In vivo interaction analysis by co-immunoprecipitation 293T cells were transfected with pEF-GATA-1 or the control eector plasmid pEF-BOS, to detect the complex of CBP and GATA-1 in the cells. The cells were washed three times with ice-cold PBS and resuspended in 0.6 mL of Harlow buer (50 mM pH 7.5 HEPES, 250 mM NaCl, 0.2 mM EDTA, 10 mM NaF, 0.5% NP-40, protease inhibitors (COM-PLETE, Boehringer Mannheim, Mannheim, Germany)) and rocked at 48C for 1 h. After centrifugation at 12 000 r.p.m. for 20 min an equal volume of Harlow buer without NaCl was added and incubated with protein G-Sepharose at 48C for 1 h. The supernatant was supplemented with anti-CBP-CT antibody (UBI, Lake Placid, NY, USA) and incubated at 48C for 3 h. After adding protein G-Sepharose, the mixture was incubated at 48C for 1 h. The Sepharose beads were washed ®ve times in Harlow buer of 125 mM NaCl. Bound proteins were eluted from the Sepharose beads and resolved by SDS ± PAGE followed by semi-dry transfer to PVDF membranes (Millipore, Bedford, MA, USA) for 1 h at room temperature. After incubation with anti-GATA-1 antibody (N6, Santa Cruz, Santa Cruz, CA, USA) for 2 h at room temperature, the blots were subsequently incubated with a secondary antibody and visualized by ECL (Amersham, Buckinghamshire, UK).
In vivo interaction analysis using the mammalian two-hybrid system A mixture containing 6 mg of the luciferase reporter plasmid driven by three tandem GAL4 binding sites, 4 mg of the GAL4-GATA-1 N-terminal zinc ®nger expression plasmid, 9 mg of either the Myb-VP16TA or VP16TA expression plasmid, and 1 mg of pact-b-gal plasmid was transfected into 293T cells, and luciferase assays were performed as described above. The total amount of plasmid DNA was adjusted to 20 mg by the addition of the control eector plasmid. Myb was added to the pre-incubated solution and incubated at 48C for 2 h and then incubated with protein G-Sepharose (50 mL bed volume per reaction mixture, Pharmacia) at 48C for 30 min. The supernatant was incubated with anti-CBP antibody (A22, Santa Cruz, USA) at 48C for 2 h. After adding protein GSepharose, the samples were incubated at 48C for 1 h with rocking. The Sepharose beads were washed ®ve times in Harlow buer. Then the bound proteins were eluted from the Sepharose beads with SDS-sample buer and analysed using SDS ± PAGE and autoradiography.
Electrophoretic mobility shift assay
Murine c-Myb, Dc-Myb, and GATA-1 were synthesized in vitro using wheat germ extract (Promega, Madison, WI, USA). Both small scale 35 S-methionine radio-labeled and large scale unlabeled reactions were performed in parallel to normalize the relative mole ratio of the proteins. Sample mixtures containing Myb and GATA-1 protein were incubated in 10 mM Tris, pH 8.0, 5 mM EDTA, 50 mM NaCl, 1 mM DTT, for 15 min at 258C in the presence of 1 mg of poly(dl:dC) and 1 mg of sonicated calf thymus DNA. And then 5 ng of 32 P radiolabeled double stranded oligonucleotides corresponding GATA binding sites of human e-globin poromoter (5'-CGAGAGGATATCATTTT-GGAAGATGA T-3' and 5'-CTCGATCATCTTCCAAAAT-GATATCCAT-3') were added to the reaction mixtures and incubated for 15 min. In supershift experiment with anti-GATA-1 antibodies (N1 and N6) or anti-Myb antibody (5-1), the antibodies were added at the last 5 min of the incubation. Reaction mixtues were electrophoresed in 5% acrylamide gels (29 : 1 acrylamide-bisacrylamide) at 48C. Gels were dried and exposed for autoradiography. Signal of 32 P was detected and quanti®ed by Bio Imaging Analyzer (Fuji).
